Sign in with Google. Opens in new tab
bullish
Anthem Biosciences Pre-IPO: High Visibility Powered by Differentiated Capabilities
623 Views04 Jan 2025 08:43
SUMMARY
- Anthem Biosciences (1234D IN), a Contract Research, Development, and Manufacturing Organization, has filed DRHP for INR34B IPO. The proposed IPO will be only offer for sale, with no fresh issue.
- Anthem Biosciences is one of three CRDMOs that possess technological capabilities in India across ADCs, RNAi, peptides, and oligonucleotides, which are among the fastest growing in the pharmaceutical industry.
- Differentiated technological capabilities, large clientele, and exposure to commercialized molecules enhance our conviction on the sustainable growth prospect of the company. Industry backdrop is also favorable.
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Santos Ltd (STO AU): FIRB Approval For XRG's Tilt Will Be No Pushover
- Gold Miners ETF (GDX US): BIG Impact of Benchmark Change
- Nakano Refrigerators (6411 JP): Marunouchi Capital’s JPY7,900 Tender Offer
- Shin Kong (2888 TT)/Taishin (2887 TT) - Short Timer, FX Risk, Index Flows - Time To Buy Vs Peers
- SET50 Index Rebalance: Four Changes in Two Weeks; DELTA Capping Too
Top Unpaywalled Insights
More »- Overview #27 – The Big Beautiful Tragi-Comedy Continues
- HK Connect SOUTHBOUND Flows (To 13 June 2025); Volumes Up, TECH Down, HEALTHCARE Bought Big
- [IO Technicals 2025/24] Downward Momentum Lingers
- China A-Share Consumer Staples: An Analysis of the Opportunities Ahead
- Bearishness Persist in Soybeans Despite Rebound Hopes
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Loading...
x